IntelliPharmaCeutics Skyrockets On Generic Drug Treatment Concerning ADHD (NASDAQ:IPCI)

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI)

Since analyst predict that the global generic drug market has potential to generate around $170 billion plus in 2014, we would like for you to check out IntelliPharmaCeutics International ticker symbol IPCI. IntelliPharmaCeutics is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled release and targeted release oral solid dosage drugs. This Company has currently surged +131.75% Up 2.49 with over 13 million shares in play Tuesday November 19, 2013 1:19PM EST. So why is this stock attracting major investors on wall street, up around two buck and half you ask? The answer is Focalin XR(R).

Focalin XR(R) is a drug targeting the treatment of attention deficit hyperactivity disorder and is marketed by Novartis Pharmaceuticals Corporation. Attention deficit hyperactivity disorder categorizes as a range of behavioral disorders occurring mainly in adolescents displaying symptoms such as impulsive, hyperactive, and poor concentration. The global market for drug treatments concerning central nervous system disorders is anticipate to touch around $4 billion within 2 years from now. The ace with a kicker concerning IntelliPharmaCeutics (www.intellipharmaceutics.com), is that the U.S. Food and Drug Administration approved their application in reference of a generic version of Focalin XR(R). Commercial sale of the 15 and 30 mg strengths is expected to be launched immediately in collaboration with Par Pharmaceutical, Inc.

****

Crown Equity Holdings Inc. (OTCMKTS:CRWE)

With the prospect of the United States ecommerce generating around $262.3 billion in sales this year through internet conducted transactions, let’s focus our attention towards Crown Equity Holdings Inc. ticker symbol CRWE. Crown Equity Holdings specializes in a vast array of network services concerning website distribution and development,  investor relations, human resources, video streaming through CRWETube (http://crwetube.com/) and advertisement. The chip up concerning Crown Equity Holdings (http://crownequityholdings.com) is iB2B Global. 

iB2B Global is a global B2B trade online directory for wholesale and retailers. To view iB2B Global short form business plan visit URL(http://crownequityholdings.com/extras/iB2BGlobal_business_plan.pdf) via the internet. iB2B Global expects to achieve $10 to $15 million in total EBITA by the end of their third year. Crown Equity Holdings has gained +718.18% positive traction concerning their 52 week low. Smart analyst could predict that Crown Equity Holdings is in a great position concerning investor returns, as the U.S. tech market expects to grow around 7.5% by the end of 2013.  

Remember: Always do your homework and consult your own financial professional.

Read Full Disclaimer at http://crweselect.com/disclaimer/